Funding for this research was provided by:
National Natural Science Foundation of China (81704096, 81603635, 81873317)
the Municipal Science and Technology Commission of Shanghai-TCM key project (16401970100)
the Shanghai TCM Medical Center of Chronic Disease (2017ZZ01010)
the National Thirteenth Five-Year Science and Technology Major Special Project for New Drug Innovation and Development (2017ZX09304001)
Received: 20 June 2019
Accepted: 11 May 2020
First Online: 10 June 2020
Ethics approval and consent to participate
: Each author certifies that Ethics committee of Longhua Hospital Research Ethics Committee (No. 2016LCSY030) approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
: All authors have agreed to publish this study.
: The authors declare that they have no competing interests.